A synthetic peptide-based polyoxime vaccine construct of high purity and activity
- 31 October 1995
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 32 (14-15) , 1031-1037
- https://doi.org/10.1016/0161-5890(95)00090-9
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Oral administration of an antigenic synthetic lipopeptide (MAP-P3C) evokes salivary antibodies and systemic humoral and cellular responsesVaccine, 1994
- Synthesis of Proteins by Native Chemical LigationScience, 1994
- Vaccine technologies: view to the futureScience, 1994
- Vaccines: a study in contrastsScience, 1994
- Synthesis of Peptide DendrimerJournal of the American Chemical Society, 1994
- Facile synthesis of homogeneous artificial proteinsJournal of the American Chemical Society, 1994
- New strategies for using mucosal vaccination to achieve more effective immunizationVaccine, 1994
- Protein conjugates of defined structure: Synthesis and use of a new carrier moleculeBioconjugate Chemistry, 1993
- A rational design of synthetic peptide vaccine with a built‐in adjuvantInternational Journal of Peptide and Protein Research, 1992
- Constructing Proteins by Dovetailing Unprotected Synthetic Peptides: Backbone-Engineered HIV ProteaseScience, 1992